ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,965Medicare Part D Prescriptions Filled, Including Refills

Rank: 1065 out of 3647

$639K Total Retail Price of All Prescriptions

Rank: 677 out of 3647

395 Patients Receiving at Least One Drug in Part D
92%Patients 65 Years and Older
61% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

10% of this provider’s 395 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

2% of this provider’s 7,915 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

38% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$71 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
OMEPRAZOLE 376 325 1 3
IBUPROFEN 259 222 2 55
SIMVASTATIN 225 200 3 1
AMLODIPINE BESYLATE 200 185 4 2
NEXIUM 186 164 5 44
DIOVAN 172 166 6 40
PLAVIX 162 153 7 39
METOPROLOL SUCCINATE 161 149 8 18
METFORMIN HCL 148 130 9 6
FUROSEMIDE 147 127 10 8
CLOPIDOGREL 145 139 11 26
ATENOLOL 143 128 12 10
AZITHROMYCIN 137 120 13 34
ALPRAZOLAM 128 115 14 31
PROPRANOLOL HCL 127 125 15 156
CRESTOR 121 94 16 19
SYNTHROID 117 115 17 42
DIOVAN HCT 111 111 18 80
LEVOTHYROXINE SODIUM 109 100 19 5
ESCITALOPRAM OXALATE 101 88 20 65
LIDODERM 94 81 21 108
LISINOPRIL 93 71 22 4
MECLIZINE HCL 88 88 23 85
MEGESTROL ACETATE 84 84 R 24 138
CELEBREX 82 74 25 111
LOSARTAN POTASSIUM 81 81 26 11
LOSARTAN-HYDROCHLOROTHIAZIDE 78 78 27 48
ZOLPIDEM TARTRATE 78 62 27 14
METOPROLOL TARTRATE 77 77 29 7
TEMAZEPAM 75 75 30 47
SPIRONOLACTONE 71 63 31 77
SERTRALINE HCL 70 68 32 27
VOLTAREN 69 69 33 102
BYSTOLIC 68 68 34 158
CLOTRIMAZOLE-BETAMETHASONE 65 36 35 84
ACETAMINOPHEN-CODEINE 63 53 S3 36 149
HYDROCHLOROTHIAZIDE 61 56 37 9
WARFARIN SODIUM 60 60 38 15
LANTUS 58 39 39 59
CARVEDILOL 57 30 40 20
VYTORIN 56 56 41 191
PREDNISONE 54 44 42 43
LOVAZA 50 50 43 117
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 5, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.